Since its foundation in 1997, Genesis Pharma SA has established itself as the premier marketer and distributor of biopharmaceutical products in Greece, Cyprus and 5 countries of South-eastern Europe.  With its core business activity focusing on in-licensing, marketing, sales and distribution of specialized pharmaceutical products stemming from biotechnology research, Genesis Pharma has forged powerful strategic alliances through exclusive agreements with leading American and European companies of cellular and molecular technology, such as Amgen, Biogen Idec, Celgene, Cephalon, Shire and Vifor.

The company has introduced and marketed an impressive portfolio of products in the region covering the fields of the Central Nervous System, Genetic Disorders, Haematology, Nephrology, Oncology and Rheumatology.

Today, Genesis Pharma is one of the fastest growing Greek pharmaceutical companies and is ranked within the leading companies of the commercial sector, with sales exceeding €153 million in 2006. 

Since its establishment, Genesis Pharma has recognized and encouraged its employees' participation in its accomplishments and has provided an ideal place to work.  That is why, for the fifth consecutive year the company was ranked among the top 10 companies for offering an excellent working environment in Greece (2003 - 2007) at the annual "Best Workplaces" competition.  In addition, it implements a social responsibility programme that includes initiatives which support children with special needs and activities that promote Greek business and culture.

Furthermore, Genesis Pharma was the only Greek pharmaceutical company to be listed among the fastest growing European companies included in the 2006 Europe's 500 Listing, the annual ranking of high growth, job-creating companies published by Europe's 500 - Entrepreneurs for Growth.

The company's main strategic objectives focus on establishing new partnerships and enriching the product portfolio, achieving rapid sales growth for newly launched products and developing existing products.  Genesis Pharma is planning further expansion in the Balkan area, as well as investigating potential new strategic alliances and late stage product development.

For more information, please visit:
www.genesispharma.gr